Skip to main content
. 2020 Jan 15;9(2):e014402. doi: 10.1161/JAHA.119.014402

Table 4.

Incidences and Rates of MACE at 4 Years of Follow‐Up

All Total Established Disease Any CADa Any CVDa Any PADa Multiple Risk Factors Only
N=625 951 Events/100 PY (95% CI) n (%) N=217 536 Events/100 PY (95% CI) n (%) N=110 456 Events/100 PY (95% CI) n (%) N=48 160 Events/100 PY (95% CI) n (%) N=87 838 Events/100 PY (95% CI) n (%) N=408 415 Events/100 PY (95% CI) n (%)
MACE 1.89 (1.87–1.91) 2.58 (2.54–2.61) 2.70 (2.65–2.76) 3.34 (3.26–3.43) 2.54 (2.49–2.60) 1.54 (1.53–1.56)
43 428 (6.9) 19 859 (9.1) 10 542 (9.5) 5539 (11.5) 7853 (8.9) 23 569 (5.8)
Myocardial infarction 1.11 (1.10–1.13) 1.54 (1.52–1.57) 1.89 (1.84–1.93) 1.37 (1.31–1.42) 1.53 (1.49–1.58) 0.90 (0.88–0.91)
25 918 (4.1) 12 088 (5.6) 7443 (6.7) 2337 (4.9) 4810 (5.5) 13 830 (3.4)
Ischemic stroke 0.95 (0.93–0.96) 1.21 (1.18–1.23) 0.95 (0.92–0.98) 2.36 (2.28–2.43) 1.15 (1.12–1.19) 0.81 (0.80–0.83)
22 051 (3.5) 9487 (4.4) 3800 (3.4) 3975 (8.3) 3631 (4.1) 12 564 (3.1)
Cardiovascular death 0.17 (0.17–0.18) 0.25 (0.24–0.26) 0.23 (0.22–0.25) 0.33 (0.31–0.36) 0.28 (0.26–0.30) 0.14 (0.13–0.14)
4123 (0.7) 1985 (0.9) 949 (0.9) 580 (1.2) 904 (1.0) 2138 (0.5)

CAD indicates coronary artery disease; CVD, cerebrovascular disease; MACE, major adverse cardiovascular event; PAD, peripheral artery disease; PY, person‐years.

a

These cohorts overlap each other.